RA CAPITAL MANAGEMENT, L.P. - Significant Ownership

Signature - Title
Rajeev Shah - Authorized Signatory
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by RA CAPITAL MANAGEMENT, L.P..

Significant Ownership of RA CAPITAL MANAGEMENT, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VOR VOR BIOPHARMA INC. Common Stock, par value $0.0001 per share 31.9% $39.3M 39.7M RA Capital Management, L.P. Dec 26, 2024
ABOS Acumen Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 24.8% $19.1M 15M RA Capital Management, L.P. Mar 27, 2025
SION SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share 23.7% $179M 10.4M RA Capital Management, L.P. Feb 10, 2025
TYRA TYRA BIOSCIENCES, INC. Common Stock, $0.0001 par value per share 20.1% $115M 10.7M RA Capital Management, L.P. Mar 27, 2025
JANX JANUX THERAPEUTICS, INC. Common Stock, par value $0.001 per share 19.9% $381M 12M RA Capital Management, L.P. Mar 6, 2025
ETNB 89BIO, INC. Common Stock, par value $0.001 per share 13.7% $143M 20M RA Capital Management, L.P. Feb 27, 2025
NAMS NEWAMSTERDAM PHARMA COMPANY N.V. Ordinary Shares, nominal value EUR0.12 per share 9.9% $254M 10.9M RA Capital Management, L.P. Dec 31, 2024
MLYS MINERALYS THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 9.9% $84.9M 6.29M RA Capital Management, L.P. Mar 13, 2025
SLDB SOLID BIOSCIENCES INC. Common Stock, $0.001 par value per share 9.9% $32M 7.99M RA Capital Management, L.P. Feb 19, 2025
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 9.9% $18.9M 4.56M RA Capital Management, L.P. Dec 31, 2024
MNPR Monopar Therapeutics Inc. Common Stock, par value $0.001 per share 9.9% $18.3M 620K RA Capital Management, L.P. Dec 31, 2024
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 9.9% $14M 3.43M RA Capital Management, L.P. Dec 31, 2024
UNCY Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share 9.9% $6.8M 11.5M RA Capital Management, L.P. Dec 31, 2024
CRVO CervoMed Inc. Common Stock, $0.001 par value 9.9% $5.3M 916K RA Capital Management, L.P. Dec 31, 2024
ADGM Adagio Medical Holdings, Inc. Common Stock, par value $0.0001 per share 9.9% $1.81M 1.61M RA Capital Management, L.P. Dec 31, 2024
DNTH Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share 9.4% $61M 2.87M RA Capital Management, L.P. Dec 31, 2024
VRNA Verona Pharma plc Ordinary Shares, nominal value GBP0.05 per share 8.9% $526M 7.78M RA Capital Management, L.P. Dec 31, 2024
DAWN DAY ONE BIOPHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share 5.7% $49.5M 5.76M RA Capital Management, L.P. Dec 31, 2024
STRO Sutro Biopharma, Inc. Common Stock, $0.001 par value per share 5.3% $8.34M 4.43M RA Capital Management, L.P. Mar 28, 2025
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 4.9% $4.12M 3.22M RA Capital Management, L.P. Dec 31, 2024
EYPT EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 4.7% $23.3M 3.18M RA Capital Management, L.P. Dec 31, 2024
BIOA BIOAGE LABS, INC. Common Stock, par value $0.00001 per share 3.7% $5.5M 1.31M RA Capital Management, L.P. Dec 31, 2024
EVH Evolent Health, Inc. Class A Common Stock, par value $0.01 per share 3.1% $31.1M 3.58M RA Capital Management, L.P. Dec 31, 2024
RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share 2% $47.7M 7.73M RA Capital Management, L.P. Dec 31, 2024
CYBN Cybin Inc. Common Shares, no par value 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
TNYA Tenaya Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
ANTX AN2 THERAPEUTICS, INC. Common Stock, $0.00001 par value per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
ANRO Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
ENSC Ensysce Biosciences, Inc. Common Stock, par value $0.0001 per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
GLYC GlycoMimetics, Inc. Common Stock, par value $0.001 per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
LBPH LONGBOARD PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
MGNX Macrogenics, Inc. Common Stock, par value $0.01 per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024
CTKB CYTEK BIOSCIENCES, INC. Common Stock, par value $0.001 per share 0% $0 0 RA Capital Management, L.P. Dec 31, 2024

Schedules 13D/G Reported by RA CAPITAL MANAGEMENT, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.